FGFR4 and metabolic dysfunction-associated steatohepatitis: We confirmed that FXR and FGFR4 mRNA expression were downregulated in the livers of our mice with histologically confirmed NASH, and the expression of these bile regulating receptors was reversed in mice treated with proglumide.